📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-19 10:42
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
Supreme Court Admits Supriya Lifescience Petition; Grants Interim Protection From Coercive Action
Supriya Lifescience informed the exchanges on October 19, 2026, regarding ongoing judicial proceedings. The Hon'ble Supreme Court of India has admitted the company's petition and listed the matter for hearing. Importantly, the Court granted interim relief directing that no coercive action shall be taken against the Directors, officers, or officials of the company. The underlying matter remains sub judice with specific financial implications not disclosed in the filing.
Confidence: MEDIUM
What changedThe Supreme Court has admitted Supriya Lifescience's petition and granted interim protection against coercive action against its officials.
Why it mattersProvides temporary legal and operational relief to management and key personnel, though the underlying case outcome remains unresolved and sub judice.
Announcement Date: October 19, 2026Financial exposure claimed: not disclosed
📅 Short termRemoves immediate overhang of coercive operational or executive disruption due to interim protection.
📈 Long termFinal resolution will depend on the Supreme Court's subsequent hearings and final judgment.
⚠ Risk flags
- Litigation risk pending before the Supreme Court
- Lack of disclosure on underlying exposure or allegations
Key Highlights
Supreme Court admitted the petition and listed the matter for hearing as of October 19, 2026
Interim relief granted directing no coercive action against directors, officers, or officials
Matter remains pending and sub judice before the Supreme Court
Financial or operational exposure under the litigation is not disclosed
👀 What to Watch
Monitor subsequent disclosures regarding the nature and any quantified exposure of the litigation, as well as final orders from the Supreme Court.
Krishival Foods Appoints FMCG Veteran Vivek Kumar Jain as Chief Business Officer
Krishival Foods Limited has appointed Vivek Kumar Jain as Chief Business Officer, effective October 23, 2026. Mr. Jain brings over 25 years of FMCG leadership experience, having spent 18 years at Nestlé and 7 years at Tata Consumer Products. In his new role, he will oversee business strategy, profitability, and distribution expansion across Modern Trade, E-commerce, Quick Commerce, and Exports. This senior appointment aligns with the company's stated goal to scale its healthy snacks and ice cream segments from its current TTM revenue base of Rs 332 crore.
Confidence: HIGH
What changedKrishival Foods recruited Vivek Kumar Jain as its Chief Business Officer to lead business strategy, omnichannel distribution, and export growth.
Why it mattersStrengthens executive leadership with tier-1 FMCG expertise to support Krishival's expansion across healthy snacks and dairy/ice cream businesses.
Effective date of appointment: October 23, 2026Total industry experience: Over 25 yearsTenure at Nestlé: 18 yearsTenure at Tata Consumer Products: 7 years
📅 Short termSentiment positive given the appointee's pedigree at large FMCG players, though immediate operational or financial impact over days to weeks will be negligible.
📈 Long termBrings institutional execution capabilities in General Trade, Modern Trade, Quick Commerce, and Exports, which is critical as the company targets capacity ramps and multi-category expansion.
⚠ Risk flags
- Execution risk in translating large-cap FMCG playbook into a mid-cap high-growth setup
- No compensation or contractual terms disclosed
Key Highlights
Appointed Vivek Kumar Jain as Chief Business Officer effective October 23, 2026
Candidate brings over 25 years of consumer industry experience across Nestlé and Tata Consumer Products
Spent 18 years at Nestlé across India and Thailand sales and leadership roles
Spent 7 years at Tata Consumer Products scaling Modern Trade, E-commerce, and exports
👀 What to Watch
Track subsequent quarterly revenue run-rates and distribution metrics to see if omnichannel scaling improves from the current Rs 89 crore quarterly revenue base.
Krishival Foods Appoints FMCG Veteran Vivek Kumar Jain as Chief Business Officer
Krishival Foods has appointed Vivek Kumar Jain as its Chief Business Officer, effective October 23, 2026. Jain brings over 25 years of experience in the FMCG sector, including 18 years at Nestlé and 7 years at Tata Consumer Products, where he focused on Modern Trade, e-commerce, and export scaling. This senior hiring aligns with Krishival's broader target to expand retail reach to 200+ towns and scale distribution across its nuts and dairy businesses (TTM revenue: ₹332 Cr).
Confidence: HIGH
What changedMr. Vivek Kumar Jain has been appointed Chief Business Officer effective October 23, 2026.
Why it mattersThe company is targeting rapid expansion across modern trade, e-commerce, and exports, making experienced FMCG leadership crucial for executing distribution scale-up.
Effective Date: October 23, 2026Industry Experience: over 25 yearsShareholding: 0 shares
📅 Short termLimited direct operational or stock impact expected immediately as onboarding completes.
📈 Long termCould enhance omnichannel execution, modern retail penetration, and exports as the company targets quadrupling nut capacity and scaling ice cream utilization.
⚠ Risk flags
- Execution risk in translating large-FMCG experience to a mid-market scale
- None material
Key Highlights
Appointment of Mr. Vivek Kumar Jain as Chief Business Officer effective October 23, 2026
Candidate brings over 25 years of FMCG experience across Nestlé (18 years) and Tata Consumer Products (7 years)
Holds 0 shares in the company and has no relationship with existing Directors or KMPs
👀 What to Watch
Track subsequent quarterly revenue traction and margin performance in Modern Trade and E-commerce channels to evaluate execution under new commercial leadership.
Signs SECI PPA for 300 MW / 1,200 MWh FDRE Project at ₹6/Unit
ACME Solar Holdings, through its subsidiary ACME Greentech Twenty Pvt Ltd, has signed a Power Procurement Agreement (PPA) with SECI for a 300 MW / 1,200 MWh firm and dispatchable renewable energy (FDRE) project under the FDRE-IX tranche. The contract features an attractive peak tariff of ₹6 per unit, with an effective date of October 6, 2026. This agreement increases ACME Solar's under-construction PPA-signed portfolio to 4,310 MW, out of a total under-construction contracted capacity of 5,380 MW. The project requires supplying 4 MWh per MW daily during non-solar hours at 90% monthly availability, integrating Solar and BESS assets.
Confidence: HIGH
What changedFormalized an offtake agreement by signing a definitive PPA with SECI for 300 MW / 1,200 MWh FDRE capacity.
Why it mattersSecures long-term revenue visibility at a premium tariff of ₹6/unit, expanding ACME's high-margin FDRE/BESS asset base with a sovereign-backed central counterparty.
Contracted Capacity: 300 MW / 1,200 MWhPPA Tariff: INR 6 per unitPPA Signed Under Construction Capacity: 4,310 MWTotal Contracted Portfolio: 8,370 MWOperational Capacity: ~3,123 MW
📅 Short termValidates project pipeline monetization and strengthens investor sentiment regarding ACME's FDRE execution capabilities.
📈 Long termSupports transition toward firm, dispatchable green power, bolstering stable, high-margin cash flows backed by central offtaker SECI over multi-decade operational horizons.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- BESS component supply chain and price volatility
- Penalties if availability falls below the 90% monthly requirement
- Execution and grid integration risks for complex hybrid storage
Key Highlights
Signed PPA with SECI for 300 MW / 1,200 MWh peak supply under FDRE-IX at ₹6 per unit
Effective date of the PPA is set as October 06, 2026
Under-construction PPA-signed contracted portfolio advances to 4,310 MW out of 5,380 MW total pipeline
Requires minimum availability of 90% on a monthly basis, supplying 4 MWh/MW for four hours daily during non-solar hours
Overall diversified contracted portfolio reaches 8,370 MW, with ~3,123 MW operational
👀 What to Watch
Track execution milestones, capex financing announcements, and commissioning timelines for this BESS-integrated project, as well as signing of the remaining ~1,070 MW under-construction portfolio.
Rossari Biotech Reports Q2 FY27 Revenue Up 19% to ₹697.6 Cr, EBITDA Up 20.9% to ₹87 Cr
Rossari Biotech reported its highest-ever quarterly revenue of ₹697.6 crore for Q2 FY27, up 19.0% YoY, alongside record quarterly EBITDA of ₹87.0 crore, growing 20.9% YoY. Profit After Tax rose modestly to ₹38.9 crore, impacted by higher depreciation from ongoing capital investments. The company witnessed robust export sales reaching ₹216.4 crore (up 33.8% YoY) and generated ₹131 crore in operating cash flows. In addition, the Board approved leasing land for a greenfield facility in Saudi Arabia, while net debt declined by ₹60 crore to ₹221 crore since March 2026.
Confidence: HIGH
What changedRossari reported record quarterly revenue and EBITDA for Q2 FY27 and approved land leasing for a greenfield manufacturing unit in Saudi Arabia.
Why it mattersDemonstrates operational scaling, balance sheet deleveraging (net debt down ₹60 Cr), and an expanding international manufacturing presence.
Q2 FY27 Revenue: Rs. 697.6 croresQ2 FY27 EBITDA: Rs. 87.0 croresQ2 FY27 PAT: Rs. 38.9 croresOperating Cash Flow: Rs. 131 croresNet Debt: Rs. 221 crores
📅 Short termSolid operational results and deleveraging provide near-term earnings support following a 32% 12-month share price decline.
📈 Long termExpansion into Saudi Arabia and commissioning of dedicated storage facilities position Rossari well to sustain its 15% long-term growth ambitions.
⚠ Risk flags
- Higher depreciation from capex muting PAT growth
- Raw material price volatility impacting gross margins
- Geopolitical uncertainties affecting export freight and supply chains
Key Highlights
Highest-ever quarterly revenue of ₹697.6 crore, up 19.0% YoY
Record EBITDA of ₹87.0 crore with margins expanding 20 bps to 12.5%
Export sales surged 33.8% YoY to ₹216.4 crore
Operating cash flow was strong at ₹131 crore, reducing net debt to ₹221 crore
Board approved leasing land for a greenfield manufacturing plant in Saudi Arabia
👀 What to Watch
Track the execution timeline and capex guidance for the greenfield facility in Saudi Arabia, as well as margin sustainability amidst volatile raw material prices.
Rossari Biotech Q2FY27 Revenue Rises 19% YoY to ₹697.6 Cr; Approves Land Lease for KSA Plant
Rossari Biotech released its Q2 & H1 FY27 investor presentation, reporting highest-ever quarterly revenue of ₹697.6 crore, up 19.0% YoY, and EBITDA of ₹87.0 crore, up 20.9% YoY. PAT rose marginally by 5.4% YoY to ₹38.9 crore, constrained by higher depreciation from ongoing investments. The company also announced Board approval for leasing land via wholly owned subsidiary RILC to build a greenfield manufacturing unit in Saudi Arabia. Net working capital cycle improved to 86 days from 97 days in March 2026, and net debt declined to ₹221 crore.
Confidence: HIGH
What changedRossari delivered solid top-line and operating profit growth in Q2FY27 and formally approved land lease for setting up an overseas manufacturing base in Saudi Arabia.
Why it mattersDemonstrates operating leverage and export traction in specialty chemicals while expanding geographic footprint into the Middle East to de-risk domestic concentration.
Q2FY27 Revenue: Rs. 697.6 croresQ2FY27 EBITDA: Rs. 87.0 croresQ2FY27 PAT: Rs. 38.9 croresQ2 Export Revenue: Rs. 216.4 croresNet Debt (Sep 2026): Rs. 221 crores
📅 Short termStable performance with revenue and EBITDA reaching record quarterly highs may support market sentiment, although PAT growth remains moderate due to depreciation.
📈 Long termExpanding presence into KSA along with commissioning of new product lines and storage facilities supports multi-year revenue growth targets of ₹3,500 Cr.
⚠ Risk flags
- Input cost volatility and delayed raw material pass-through
- Execution and regulatory risks associated with the greenfield facility in Saudi Arabia
- High depreciation burden dampening near-term net earnings
Key Highlights
Q2FY27 total revenue grew 19.0% YoY to ₹697.6 crore, driven by a 33.8% surge in exports to ₹216.4 crore
EBITDA grew 20.9% YoY to ₹87.0 crore with an EBITDA margin of 12.5%
PAT reached ₹38.9 crore, growing 5.4% YoY due to elevated depreciation expenses
Net debt was reduced from ₹281 crore (March 2026) to ₹221 crore as of September 2026
Board approved land leasing for a greenfield facility in the Kingdom of Saudi Arabia (KSA)
👀 What to Watch
Track capex updates and timeline disclosures for the newly approved Saudi Arabia manufacturing plant, along with margin trajectory in upcoming quarters.
Orissa HC Quashes/Sets Aside JSW Steel's Mining Shortfall Demands Worth ~Rs 2,169 Cr
JSW Steel announced favorable outcomes from the Hon'ble High Court of Orissa regarding two mineral dispatch shortfall demands for the Jajang Iron Ore Block. The High Court effectively quashed a Year 1 demand of Rs 696.32 Cr and set aside a Year 5 demand of Rs 1,472.69 Cr. Combined, these demands totaled approximately Rs 2,169 Cr, which is equivalent to ~7.7% of JSW Steel's TTM net profit of Rs 27,995 Cr. The court has remitted the Year 5 matter back to the mining authorities to decide afresh in light of existing legal precedent.
Confidence: HIGH
What changedThe Orissa High Court has quashed a Year 1 demand of Rs 696.32 Cr and set aside a Year 5 demand of Rs 1,472.69 Cr issued by Odisha mining authorities against the Jajang Iron Ore Block.
Why it mattersThe relief removes immediate liability of Rs 2,169 Cr (about 7.7% of TTM PAT), eliminating a significant contingent cash drain, though the Year 5 matter must still be reassessed by authorities.
Year 1 Demand Quashed: Rs. 6,96,32,09,199/-Year 5 Demand Set Aside: Rs. 14,72,69,47,420/-Total Disputed Value: Rs 2,169.01 CrTotal Demand vs TTM Net Profit: ~7.7%
📅 Short termPositive for sentiment as substantial contingent liabilities are struck down, removing legal overhangs concerning Keonjhar mining dispatches.
📈 Long termProvides regulatory and legal clarity regarding the calculation of mineral dispatch shortfalls under Rule 12-A of MCR 2016 across JSW's captive iron ore assets.
⚠ Risk flags
- Year 5 demand has been remitted to mining authorities to decide afresh, meaning a revised demand could still be raised.
Key Highlights
High Court disposed of WP (C) No. 28232 of 2021, effectively quashing a Year 1 dispatch shortfall demand of Rs. 6,96,32,09,199/-.
High Court set aside WP (C) No. 23792 of 2025 demand of Rs. 14,72,69,47,420/- for Year 5 shortfall and remitted it for fresh review.
Total disputed demand across both petitions was Rs 2,169.01 Cr under Rule 12-A of the MCR 2016.
The judgements were pronounced on October 16, 2026, referencing earlier precedent from April 20, 2026.
👀 What to Watch
Track whether the Deputy Director of Mines, Joda, issues a revised or reduced demand upon fresh assessment for the Year 5 shortfall, and whether the state files any appeal against the quashed Year 1 order.
YES BANK Q2 Net Profit jumps 65% YoY to ₹1,080 Cr; SC AT-1 ruling unrecognised
YES BANK reported a 65.0% YoY increase in Net Profit to ₹1,080 Cr for Q2 (ended September 30, 2026), driven by a 22.7% YoY growth in Net Interest Income to ₹2,822 Cr. Gross NPA ratio improved by 40 bps YoY to 1.2%, while Net NPA stood at 0.2%. However, the bank noted that the Supreme Court upheld the Bombay High Court ruling on ₹8,415 Cr Additional Tier 1 (AT-1) bonds, and the financial impact has not yet been recognized pending full assessment.
Confidence: HIGH
What changedYES BANK published its Q2FY27 financial results and investor presentation showing strong operational earnings alongside a major Supreme Court judgment upholding the cancellation of ₹8,415 Cr AT-1 bond write-downs.
Why it mattersWhile operational profitability and credit quality showed strong improvement, potential liabilities or capital dilution from ₹8,415 Cr worth of AT-1 bonds represent ~16.5% of the bank's net worth (₹51,062 Cr).
Net Profit: ₹1,080 CrNet Interest Income: ₹2,822 CrGNPA Ratio: 1.2%AT-1 Bonds under SC ruling: ₹8,415 CrAT-1 Bonds vs Net Worth: ~16.5%
📅 Short termSolid headline earnings may be overshadowed by legal uncertainty and potential provisioning or capital restructuring following the Supreme Court's AT-1 bond order.
📈 Long termThe underlying franchise shows structural operational recovery with advancing CASA, granular retail disbursements, and falling credit costs (0.3% of avg assets), provided legal headwinds from AT-1 bonds are resolved.
⚠ Risk flags
- Supreme Court upheld Bombay HC order regarding ₹8,415 Cr AT-1 bonds write-down; financial impact pending assessment and unprovided
- Cost-to-income ratio remains elevated at 64.3%
Key Highlights
Net Profit rose 65.0% YoY to ₹1,080 Cr with an RoA of 0.9% and RoE of 8.2%
Operating profit reached ₹1,678 Cr, up 29.4% YoY, while NII stood at ₹2,822 Cr (up 22.7% YoY)
Gross NPA declined 40 bps YoY to 1.2% and Net NPA improved 10 bps YoY to 0.2%
Total advances grew 23.7% YoY to ₹3,09,510 Cr; deposits rose 19.5% YoY to ₹3,54,004 Cr
Supreme Court upheld Bombay HC ruling on ₹8,415 Cr AT-1 bonds; impact not recognized in Q2 results pending assessment
👀 What to Watch
Track the upcoming analyst call on October 19, 2026, and management updates regarding the quantification, legal remedy, or capital impact of the ₹8,415 Cr AT-1 bond Supreme Court judgment.
PSB Q2 FY27 Net Profit Rises 39.7% YoY to ₹412 Cr; Gross NPA Drops to 2.09%
Punjab & Sind Bank reported a strong operational performance for Q2 FY27, with net profit rising 39.66% YoY to ₹412 crore and operating profit growing 22.38% YoY to ₹618 crore. Net Interest Income (NII) expanded 22.32% YoY to ₹1,162 crore, supported by an expansion in Net Interest Margin (NIM) to 2.77% (+17 bps YoY). Total advances grew 19.28% YoY to ₹1,25,919 crore, powered by a 31.08% YoY growth in the high-yield RAM portfolio. Asset quality continued to strengthen, with Gross NPA declining to 2.09% (down from 2.92% in Sep'25) and Net NPA reaching 0.61%.
Confidence: HIGH
What changedPSB released its investor presentation detailing reviewed financial results for Q2 FY27, showcasing improved margins, robust RAM credit growth, and multi-quarter lows in NPAs.
Why it mattersDemonstrates sustained operational turnaround and strengthening balance sheet health, though lower CASA mix points to ongoing deposit repricing headwinds.
Net Profit (Q2 FY27): ₹412 CroreOperating Profit: ₹618 CroreGross Advances: ₹125919 CroreGross NPA (%): 2.09%CRAR (%): 16.55%
📅 Short termPositive sentiment likely driven by solid profit growth, sequential NIM improvement to 2.77%, and steady asset quality improvements.
📈 Long termStrategic shift to retail, agri, and MSME (RAM) loans (>61% of advances) enhances return profile, though government shareholding remains high at ~93.85% requiring eventual dilution.
⚠ Risk flags
- CASA ratio contracted 148 bps YoY to 28.83%, indicating deposit mobilization pressure
- High government ownership (93.85%) poses long-term share supply/dilution overhang to meet minimum public shareholding norms
Key Highlights
Q2 FY27 Net Profit grew 39.66% YoY to ₹412 crore vs ₹295 crore in Q2 FY26
Net Interest Income rose 22.32% YoY to ₹1,162 crore with NIM improving by 17 bps YoY to 2.77%
Gross NPA reduced significantly to 2.09% (vs 2.92% YoY) and Net NPA stood at 0.61% (vs 0.83% YoY)
RAM advances grew 31.08% YoY to ₹77,276 crore, now constituting 61.37% of total advances
CRAR remained strong at 16.55% with CET-1 at 15.49%
👀 What to Watch
Monitor CASA deposit traction, as CASA ratio declined to 28.83% from 30.31% YoY, and track whether credit costs remain below the guided <1% ceiling for FY27.
Kross Q2 FY27 Revenue up 79.6% YoY to ₹235.1 Cr; PAT Surges 143.5% to ₹19.7 Cr
Kross Limited reported strong performance in Q2 FY27 with revenue growing 79.6% YoY to ₹235.1 crore compared to ₹130.9 crore in Q2 FY26. EBITDA rose 107.4% YoY to ₹30.6 crore with margins expanding 175 bps to 13.0%, while PAT grew 143.5% YoY to ₹19.7 crore. Commercial production of extruded axle beams commenced with current capacity at 7,500 units per month operating at 60-65% utilization. Trials for the seamless tube facility are scheduled for February-March 2027.
Confidence: HIGH
What changedKross reported sharp YoY and QoQ earnings acceleration for Q2 FY27 alongside the commencement of commercial production at its extruded axle beam plant.
Why it mattersHigher capacity utilization and backward integration into extruded axle beams and seamless tubes improve gross margins, reduce material costs, and expand export potential.
Revenue (Q2 FY27): ₹235.1 croreEBITDA Margin (Q2 FY27): 13.0%PAT (Q2 FY27): ₹19.7 croreAxle Beam Capacity: 7,500 units per monthAxle Beam Extrusion Utilisation: 60–65%
📅 Short termMarket sentiment should react positively to strong operational growth, sequential margin expansion, and commissioning of new manufacturing lines.
📈 Long termBackward integration through extruded axle beams, robotic forging, and the upcoming seamless tube plant positions the company for margin gains and international market expansion.
⚠ Risk flags
- Cyclicality in domestic commercial vehicle and tractor segments
- Execution and ramp-up risks regarding new seamless tube facility trials in early 2027
Key Highlights
Q2 FY27 Revenue grew 79.6% YoY to ₹235.1 crore vs ₹130.9 crore in Q2 FY26
Q2 FY27 EBITDA increased 107.4% YoY to ₹30.6 crore, expanding margins by 175 bps to 13.0%
PAT surged 143.5% YoY to ₹19.7 crore with EPS rising to ₹3.08 from ₹1.25
Commercial production started at India's first Axle Beam Extrusion Plant (7,500 units/month capacity) at 60-65% utilization
Seamless tube facility mills installed; production trials targeted for February-March 2027
👀 What to Watch
Track the ramp-up in utilization at the axle beam extrusion plant and watch for the outcome of seamless tube facility production trials targeted for February-March 2027.
DRI Initiates Industry-Wide Search Under Customs Act at United Spirits
United Spirits Limited disclosed that the Directorate of Revenue Intelligence (DRI) conducted searches across multiple company locations on October 16, 2026, concluding at 20:30 hrs IST. The search was initiated under Section 105 of the Customs Act, 1962, as part of an apparent industry-wide exercise. United Spirits stated that it has extended full co-operation and provided all sought documents. As of now, the company reports no quantifiable impact on its financial or operational activities.
Confidence: HIGH
What changedDRI initiated and concluded a multi-location search under the Customs Act as part of an industry-wide regulatory inquiry.
Why it mattersWhile no immediate financial impact is reported, any subsequent findings could lead to duty reassessments, penalties, or legal disputes impacting alcobev imports.
Date of search: 16th October 2026Conclusion time: 20:30 hrs ISTFinancial impact: No impact on financial, operation or other activities of the Company as of now
📅 Short termMay cause minor sentiment overhang until clarity emerges on whether any specific non-compliance or duty demand is alleged.
📈 Long termLimited, unless the DRI probe uncovers material customs duty evasion or triggers substantial retrospective tax liabilities.
⚠ Risk flags
- Potential customs duty demands or penalties following document review
- Regulatory scrutiny on imported spirits and bulk alcohol supply chain
Key Highlights
DRI initiated search operations under Section 105 of the Customs Act, 1962
Search conducted at multiple company locations on 16th October 2026
Operations concluded on 16th October 2026 at 20:30 hrs IST
Company reports no impact on financial, operational, or other activities as of now
👀 What to Watch
Track subsequent disclosures for any formal show-cause notices, duty demands, or penalties issued by the DRI.
Rossari Biotech Approves Land Lease for Greenfield Facility in Saudi Arabia; Reports H1 FY27 Results
Rossari Biotech's Board approved the leasing of land by its wholly owned subsidiary, Rossari International Limited Company, to set up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA). Total capex and project outlay are yet to be finalised and placed before the Board. On the financial front, standalone profit before tax for H1 FY27 rose 19.6% YoY to ₹92.57 Cr compared to ₹77.42 Cr in H1 FY26, alongside operating cash flow generation of ₹87.66 Cr. Five reviewed subsidiaries contributed ₹1,080.17 Cr in revenue and ₹18.99 Cr in PAT for H1 FY27.
Confidence: HIGH
What changedRossari approved leasing land in Saudi Arabia for greenfield manufacturing and released H1 FY27 financials.
Why it mattersEstablishes a local production base in the MENA region, supporting the company's international expansion and reducing cross-border freight costs.
Standalone H1 FY27 Profit Before Tax: ₹925.74 millionStandalone Operating Cash Flow H1 FY27: ₹876.62 millionReviewed Subsidiaries H1 Revenue: ₹10,801.73 millionCapital Outlay for Saudi Facility: not disclosed
📅 Short termPositive sentiment from solid standalone cash generation and continued operational scaling into international markets.
📈 Long termSetting up manufacturing in Saudi Arabia aligns with Rossari's stated MENA expansion strategy, helping diversify geographic presence and capture local market demand.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Capex size and financing mode for the Saudi greenfield facility are not yet disclosed
- Overseas project execution and cross-border regulatory risks in KSA
Key Highlights
Board approved land lease in Saudi Arabia (KSA) for a greenfield facility via subsidiary Rossari International Ltd Co; capex outlay pending final Board approval
Standalone H1 FY27 Profit Before Tax grew 19.6% YoY to ₹92.57 Cr (₹925.74 million) from ₹77.42 Cr (₹774.16 million)
Standalone net cash from operations reached ₹87.66 Cr (₹876.62 million) for H1 FY27, up sharply from ₹16.26 Cr in H1 FY26
Reviewed subsidiary cluster contributed ₹1,080.17 Cr (₹10,801.73 million) in revenue and ₹18.99 Cr (₹189.94 million) in PAT for H1 FY27
Standalone borrowings reduced as net short-term debt repayments stood at ₹40.89 Cr (₹408.90 million) in H1 FY27
👀 What to Watch
Track subsequent Board disclosures detailing the capital expenditure, production capacity, and completion timelines for the Saudi Arabia greenfield facility.
Supreme Court Upholds ₹8,415 Cr AT-1 Bond Decision; Auditors Issue Qualified Opinion on Q2
Yes Bank announced its Q2 FY27 results alongside an adverse Supreme Court ruling dated October 15, 2026, which upheld the Bombay High Court's decision setting aside the ₹8,415 crore AT-1 bond write-down from March 2020. Consequently, joint statutory auditors issued a qualified conclusion because the reported financials do not yet reflect the impact of the judgment. While reported Q2 net profit was ₹1,084 crore, the bank disclosed indicative proforma numbers showing a potential post-tax net loss of ₹5,213 crore and an increase in borrowings from ₹78,410 crore to ₹86,825 crore if recognized. The bank is evaluating legal remedies and accounting treatments.
Confidence: HIGH
What changedThe Supreme Court rejected Yes Bank and RBI appeals, confirming the Bombay High Court order that quashed the March 2020 write-down of ₹8,415 crore of AT-1 bonds.
Why it mattersThe potential reinstatement of ₹8,415 crore in AT-1 liabilities represents ~16.5% of Yes Bank's net worth (₹51,062 Cr) and would flip H1 FY27 profits into a proforma net loss of ₹4,141 crore.
AT-1 Bonds in dispute: ₹8,415 croreAT-1 Bonds vs Net Worth: ~16.5%Reported Q2 Net Profit: 1,084 croreProforma Q2 Net Loss (Post-tax): (5,213) croreReported Borrowings: 78,410 croreProforma Borrowings: 86,825 crore
📅 Short termHeightened stock volatility and negative sentiment are expected following the auditor's qualification and the large proforma loss disclosure.
📈 Long termIf permanently enforced, the liability reinstatement weakens retained earnings and net worth, potentially impacting capital generation, credit ratings, and future growth plans.
⚠ Risk flags
- Material liability of ₹8,415 crore arising from final adverse Supreme Court judgment
- Auditor qualification on standalone and consolidated financial results
- Potential book value erosion and multi-quarter earnings drag if fully provided
Key Highlights
Supreme Court dismissed appeals on October 15, 2026, upholding the invalidation of the ₹8,415 crore AT-1 bond write-down
Auditors issued a qualified opinion on Q2 results as the judgment's impact has not yet been recognized in reported accounts
Reported Q2 net profit stood at ₹1,084 crore, but proforma Q2 post-tax loss is estimated at ₹5,213 crore if the judgment is given effect
Proforma borrowings increase by ₹8,415 crore from ₹78,410 crore to ₹86,825 crore, while proforma RoA drops to -4.3% (annualized)
Reported and proforma Basel III Capital Adequacy Ratio is stated at 14.6%
👀 What to Watch
Track further legal steps by Yes Bank (such as review petitions before the Supreme Court) and regulatory guidance from the RBI regarding the timing and accounting treatment of the AT-1 bond reinstatement.
Kross Q2 FY27 PAT Jumps 143.5% YoY to ₹19.69 Cr; Revenue Up 79.6%
Kross Limited reported strong financial results for Q2 FY27, with standalone revenue increasing 79.6% YoY to ₹235.09 Cr (₹2,350.9 million) compared to ₹130.92 Cr in Q2 FY26. EBITDA rose 107.4% YoY to ₹30.60 Cr, with EBITDA margins expanding by 175 bps to 13.0%. Profit after tax surged 143.5% YoY to ₹19.69 Cr, driven by broad-based segmental recovery in M&HCVs, trailers, and tractors. Operationally, its axle beam extrusion plant achieved 60-65% utilization, and trials for the seamless tube facility are slated for February-March 2027.
Confidence: HIGH
What changedKross reported sharp YoY growth across revenue (+79.6%) and PAT (+143.5%) in Q2 FY27, supported by commercialized extrusion capacity operating at 60-65% utilization.
Why it mattersDemonstrates strong operating leverage and operational progress in expanding backward integration, supporting margin expansion from 11.3% to 13.0% EBITDA margin.
Q2 FY27 Revenue: ₹2,350.9 millionQ2 FY27 EBITDA: ₹306.0 millionQ2 FY27 PAT: ₹196.9 millionAxle beam plant utilization: approximately 60-65%Seamless tube trial timeline: February-March 2027
📅 Short termMarket sentiment should react positively to the 143.5% YoY net profit growth and margin expansion across both EBITDA and PAT metrics.
📈 Long termStructural margins and return ratios could improve as backward integration assets (extrusion and seamless tube facilities) ramp up and expand addressable content per vehicle.
⚠ Risk flags
- Cyclical demand risks inherent to M&HCV and tractor end-markets
- Execution and commissioning risk on upcoming seamless tube facility trials in early 2027
Key Highlights
Q2 FY27 Revenue from Operations up 79.6% YoY to ₹235.09 Cr (INR 2,350.9 mn)
Q2 FY27 PAT increased 143.5% YoY to ₹19.69 Cr with margin expanding 220 bps to 8.4%
EBITDA grew 107.4% YoY to ₹30.60 Cr; margin expanded 175 bps to 13.0%
Commercial production commenced at axle beam extrusion plant with current utilization at 60-65%
Seamless tube facility trials targeted for February-March 2027
👀 What to Watch
Track the commercial ramp-up and production trials of the seamless tube facility scheduled for February-March 2027, as well as margin sustainability amidst ongoing raw material pricing trends.
Punjab & Sind Bank Q2 Net Profit Jumps 39.7% YoY to ₹412 Cr; GNPA Drops to 2.09%
Punjab & Sind Bank reported a strong Q2 FY27 performance with net profit rising 39.66% YoY to ₹412 Cr, up from ₹295 Cr in Q2 FY26. Total advances grew 19.28% YoY to ₹1,25,919 Cr, led by a 31.08% expansion in RAM (Retail, Agriculture, MSME) advances, which now form 61.37% of the loan book. Asset quality improved significantly with Gross NPA falling 83 bps YoY to 2.09% and Net NPA declining 22 bps to 0.61%. Net Interest Margin expanded by 17 bps YoY to 2.77%, while the Provision Coverage Ratio improved to 92.48%.
Confidence: HIGH
What changedQ2 FY27 earnings release showing significant expansion in profitability, improved margins, and asset quality cleanup.
Why it mattersDemonstrates strengthening core operational performance driven by higher-yielding RAM loans and a cleaner balance sheet, supporting Return on Equity expansion to 13.21%.
Q2 Net Profit: ₹412 CrQ2 Total Income: ₹3747 crGross NPA ratio: 2.09%Net NPA ratio: 0.61%Total Business: ₹ 279231 CrCRAR: 16.55%
📅 Short termEarnings beat on profitability and asset quality improvement should support positive sentiment in the stock near term.
📈 Long termSustained shift toward RAM advances improves yields, though long-term re-rating depends on maintaining deposit mobilization and expanding fee income while managing zero-coupon bond drag.
⚠ Risk flags
- Deposit growth (12.97%) lagging advance growth (19.28%), which could strain liquidity or increase cost of funds
- CRAR declined 64 bps YoY to 16.55%
Key Highlights
Net Profit rose 39.66% YoY to ₹412 Cr and 24.47% QoQ from ₹331 Cr
Net Interest Income surged 22.32% YoY to ₹1,162 Cr with NIM expanding 17 bps to 2.77%
Asset quality improved with GNPA at 2.09% (down 83 bps YoY) and NNPA at 0.61% (down 22 bps YoY)
RAM advances expanded 31.08% YoY to ₹77,276 Cr, taking RAM share to 61.37%
Return on Assets improved by 16 bps YoY to 0.88%, and Cost-to-Income dropped 268 bps to 59.19%
👀 What to Watch
Track whether credit costs remain subdued and monitor if deposit growth (12.97%) can keep pace with credit growth (19.28%) without crimping NIMs in subsequent quarters.
Rossari Biotech Approves Saudi Arabia Greenfield Facility Lease; Releases H1 FY27 Financials
Rossari Biotech's Board approved the leasing of land to set up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA) via its wholly owned subsidiary Rossari International Limited Company. The overall project cost and investment plan will be finalised and submitted to the Board later. Concurrently, the company reported its H1 FY27 standalone results, showing cash flow from operations of Rs 876.62 million (up from Rs 162.62 million in H1 FY26) and standalone Profit Before Tax of Rs 925.74 million. For Q2 FY27, five key subsidiaries generated revenue of Rs 5,231.06 million with PAT of Rs 106.23 million.
Confidence: HIGH
What changedRossari approved entering into a land lease agreement in Saudi Arabia for a new greenfield facility, marking a concrete international manufacturing expansion.
Why it mattersSetting up a direct manufacturing base in KSA strengthens Rossari's presence in the Middle East and North Africa (MENA) market, a core pillar of its international growth strategy.
Standalone PBT (H1 FY27): Rs 925.74 millionStandalone Operating Cash Flow (H1 FY27): Rs 876.62 millionFive Subsidiaries Q2 Revenue: Rs 5,231.06 millionFive Subsidiaries Q2 PAT: Rs 106.23 millionKSA Capex / Investment: not disclosed
📅 Short termMarket sentiment should be supported by steady operational cash flows and the formal clearance to secure land in Saudi Arabia.
📈 Long termA manufacturing footprint in the Middle East offers logistic advantages, proximity to key raw materials, and closer access to export markets across the MENA region.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Project execution risk in an overseas jurisdiction
- Overall capital expenditure and funding structure for the Saudi unit remain undisclosed
Key Highlights
Board approved leasing of land for a greenfield manufacturing unit in Saudi Arabia via wholly owned subsidiary Rossari International Limited Company.
Standalone H1 FY27 Profit Before Tax reached Rs 925.74 million compared to Rs 774.16 million in H1 FY26.
Standalone cash flow from operations surged to Rs 876.62 million in H1 FY27 from Rs 162.62 million in H1 FY26.
Five unreviewed subsidiaries contributed Rs 5,231.06 million in revenue and Rs 106.23 million in PAT during the quarter ended September 30, 2026.
👀 What to Watch
Track subsequent announcements regarding the detailed project plan, capex outlay, and expected commissioning timeline for the Saudi Arabian greenfield plant.
JSW Cement Wins Orissa HC Ruling for SGST Incentives and Interest under IPR 2015
The Hon'ble High Court of Orissa ruled in favor of JSW Cement on October 16, 2026, setting aside the August 18, 2020 amendment that retrospectively excluded cement units from SGST reimbursements starting July 1, 2017. The court granted deemed approval of the company's August 16, 2017 application for Priority Sector status under the Industrial Policy Resolution (IPR) 2015. Crucially, the court directed the State to determine and release JSW Cement's SGST reimbursement claim, along with applicable interest, within four weeks. While the precise monetary claim was not disclosed in the filing, this outcome paves the way for a cash inflow relative to its TTM revenue of ₹6,849 Cr.
Confidence: HIGH
What changedJSW Cement won its legal challenge against the Orissa government's retrospective cancellation of SGST reimbursements under IPR 2015.
Why it mattersThe ruling entitles JSW Cement to recover past accumulated SGST incentives plus interest, creating a potential one-time cash inflow and improving operational cash flows from its Odisha operations.
Judgment date: 16th October, 2026Release timeline directed by Court: within four weeksRetrospective exclusion start date set aside: 1st July, 2017Application date for Priority Sector status: 16th August, 2017Total claim value: not disclosed
📅 Short termPositive sentiment from a favorable legal outcome that enforces incentive disbursement within four weeks, subject to potential appellate challenges by the State.
📈 Long termProtects industrial incentive entitlements under IPR 2015 for manufacturing facilities in Odisha, improving project economics and reinforcing the doctrine of promissory estoppel against retrospective policy changes.
⚠ Risk flags
- Risk of appeal by the State of Odisha in the Supreme Court
- Total quantum of the reimbursement claim not disclosed in the document
Key Highlights
Orissa High Court judgment dated October 16, 2026, allows JSW Cement's Writ Petition No. 36871 of 2020.
Sets aside the retrospective amendment dated August 18, 2020, which had excluded cement units from SGST reimbursements effective July 1, 2017.
Confirms deemed approval of the company's Priority Sector application dated August 16, 2017, under IPR 2015.
Directs the State authorities to determine and release the accrued SGST reimbursement claim with interest within four weeks.
👀 What to Watch
Track the upcoming quarterly financial disclosures to see the quantified determination and realization of the SGST reimbursement amount and interest, as well as whether the State files an appeal before the Supreme Court.
Himadri Q2 FY27 Consolidated Revenue Hits ₹1,691 Cr, PAT Up at ₹231 Cr
Himadri Speciality Chemical reported consolidated Q2 FY27 revenue of ₹1,691 Cr, up 57.9% YoY compared to ₹1,071 Cr in Q2 FY26. Consolidated PAT reached ₹231 Cr versus ₹176 Cr in Q2 FY26, while EBITDA grew to ₹303 Cr from ₹238 Cr. Standalone sales volumes stood at 1,46,806 MT in Q2 FY27 compared to 1,35,513 MT in Q2 FY26. The presentation highlights a strategic restructuring involving the demerger and vesting of DBRL's Tyre Business into HSCL (appointed date October 1, 2026), alongside continuing expansion into battery materials.
Confidence: HIGH
What changedHSCL published its comprehensive Q2 FY27 investor presentation containing updated quarterly financials and strategic progress on tyre demerger and clean energy investments.
Why it mattersDemonstrates strong top-line scale up to ₹1,691 Cr and steady PAT expansion, reinforcing HSCL's ongoing transition toward high-margin speciality chemicals and battery materials.
Q2 FY27 Consolidated Revenue: ₹1,691 CrQ2 FY27 Consolidated PAT: ₹231 CrQ2 FY27 EBITDA: ₹303 CrH1 FY27 Net Operating Cash Flow: -₹154.35 CrConsolidated Borrowings (Sep 2026): ₹1,155.84 Cr
📅 Short termSolid operational performance in Q2 FY27 will likely support sentiment, though working capital drag in H1 cash flows will be watched.
📈 Long termIntegration of the tyre business and diversification into lithium-ion battery materials provide long-term growth avenues beyond traditional coal tar derivatives.
⚠ Risk flags
- Negative consolidated cash flow from operations of ₹154.35 Cr in H1 FY27 due to ₹686.25 Cr working capital expansion
- Execution and regulatory approvals pending for DBRL tyre business demerger
Key Highlights
Q2 FY27 consolidated revenue stood at ₹1,691 Cr, up from ₹1,071 Cr in Q2 FY26
Consolidated Q2 FY27 PAT reached ₹231 Cr compared to ₹176 Cr in Q2 FY26
Q2 FY27 EBITDA reached ₹303 Cr versus ₹238 Cr in Q2 FY26
Standalone sales volume rose to 1,46,806 MT in Q2 FY27 from 1,35,513 MT in Q2 FY26
Tyre business demerger from DBRL into HSCL approved with appointed date of 1 Oct 2026
👀 What to Watch
Monitor regulatory and shareholder approvals for the tyre business demerger from DBRL, as well as working capital trends following consolidated operating cash outflow of ₹154.35 Cr in H1 FY27.
Q2 FY27 Consolidated PAT Rises 31.3% YoY to ₹231 Cr; Revenue Up 57.9% to ₹1,691 Cr
Himadri Speciality Chemical reported a 57.93% YoY increase in consolidated revenue from operations for Q2 FY27 to ₹1,691 crore (compared to ₹1,071 crore in Q2 FY26). Consolidated EBITDA for the quarter rose 27.48% YoY to ₹303 crore from ₹238 crore, while PAT grew 31.33% YoY to ₹231 crore versus ₹176 crore. For H1 FY27, revenue reached ₹3,123 crore (up 43% YoY) with EBITDA of ₹616 crore (up 30% YoY) and PAT of ₹460 crore (up 29% YoY). The company noted operational progress including the proposed merger of Birla Tyres and its investment in Sicona Battery Technologies.
Confidence: HIGH
What changedHSCL reported strong Q2 and H1 FY27 earnings momentum, achieving record quarterly revenues of ₹1,691 crore and net profit of ₹231 crore.
Why it mattersDemonstrates robust top-line acceleration driven by core expansion and value-added materials, supporting the company's premium valuation multiple.
Q2 FY27 Revenue: ₹ 1,691 CrQ2 FY27 PAT: ₹ 231 CrQ2 FY27 EBITDA: ₹ 303 CrH1 FY27 Revenue: ₹ 3,123 CrSicona ARENA Funding: AUD 45 million
📅 Short termEarnings outperformance is likely to support positive sentiment around operational ramp-ups.
📈 Long termStrategic integration of Birla Tyres and commercialization of advanced battery materials (anodes, LFP) provide structural growth avenues.
⚠ Risk flags
- EBITDA margin compression relative to revenue growth (EBITDA grew 27.5% vs revenue 57.9%)
- Integration and execution risks related to Birla Tyres merger
Key Highlights
Q2 FY27 Revenue from Operations jumped 57.93% YoY to ₹1,691 crore from ₹1,071 crore in Q2 FY26
Q2 FY27 Consolidated PAT rose 31.33% YoY to ₹231 crore compared to ₹176 crore in Q2 FY26
Q2 FY27 EBITDA increased 27.48% YoY to ₹303 crore vs ₹238 crore in Q2 FY26
H1 FY27 revenue crossed ₹3,123 crore (+43% YoY) with PAT at ₹460 crore (+29% YoY)
Sicona Battery Technologies secured AUD 45 million from ARENA and acquired Advano (USA)
👀 What to Watch
Track subsequent margin sustainability given EBITDA growth lagged top-line growth, and monitor regulatory approvals regarding the Birla Tyres merger.
Karur Vysya Bank Q2 FY27 Concall: Total Business Reaches ₹2,39,712 Cr, Up 18% YoY
Karur Vysya Bank reported a total business of ₹2,39,712 crore as of September 30, 2026, marking an 18% YoY and 5% QoQ growth. Total advances grew 7% QoQ to ₹1,11,589 crore, while deposits increased 5% QoQ to ₹1,28,123 crore. The RAM (Retail, Agriculture, MSME) segment continues to dominate the book at 86%, while the jewel loan portfolio reached ₹32,153 crore (29% of advances). Management has guided for a calibrated full-year credit growth target of 18% to 20% while prioritising margins and maintaining Return on Assets (ROA) around 2.0-2.1%.
Confidence: HIGH
What changedSubmission of the detailed earnings conference call transcript for the quarter ended September 30, 2026.
Why it mattersProvides detailed management commentary on loan portfolio distribution, CASA traction, jewel loan LTV limits, and strategic growth guidance of 18-20% for the fiscal year.
Total Business: ₹2,39,712 croreTotal Advances: ₹1,11,589 croreTotal Deposits: ₹1,28,123 croreJewel Loan Portfolio: ₹32,153 croreFull-Year Credit Growth Guidance: 18% to 20%
📅 Short termStable operational performance and cautious management guidance indicate balanced growth with disciplined yield management over coming months.
📈 Long termSustained focus on the high-yielding RAM segment (86% mix) alongside calibrated branch expansion beyond South India into Maharashtra and Gujarat supports steady ROA.
⚠ Risk flags
- Competitive pressure on asset yields could challenge NIM sustainability
- Corporate slippages or large-ticket concentration risks
Key Highlights
Total business reached ₹2,39,712 crore, up 18% YoY and 5% QoQ
Advances grew 7% QoQ to ₹1,11,589 crore (YTD advances up 13%), with full-year growth guided at 18-20%
Total deposits stood at ₹1,28,123 crore (+5% QoQ), supported by a ₹1,489 crore increase in CASA balances
Jewel loan portfolio stood at ₹32,153 crore (29% of total advances) with an LTV of 67% for Agri and 59% for non-Agri
Management reaffirmed intent to defend net interest margins rather than chasing aggressive low-yield volume
👀 What to Watch
Track the upcoming Q3 FY27 credit growth and margin trajectory to see if the bank sustains its 18-20% full-year growth target without compromising yield or asset quality.
